Skip to content

Study · Animal study (in vivo) · rat · 2003

5 results

[New regulatory peptides in rat stomach secretion (amylin, PGP, semax)].

Maev IV, Dicheva DT

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology1 Jan 2003

PMID12875006 (opens in a new tab)PepBankPUB-12875006

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study5

5 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In rats, intraperitoneal semax decreased basal production of hydrochloric acid in the stomach.

    In plain wordsIn rats, semax lowered the normal production of stomach acid.

    Peptide
    Semax
    Outcome
    DecreaseBasal hydrochloric acid production
    Study

    ratn: not reported in source

    Continuous stomach perfusion
    Outcome group
    Gastrointestinal protection · Gastrointestinal
    Studied dose
    Dose not stated · intraperitonealAs given in this study (rat).

    Source sentences

    Summary
    The intraperitoneal introduction of these peptides in the doses that proved to have an apparent anti-ulcer effect caused a decrease of both basal production of hydrochloric acid in the stomach and production caused by the irritation of the vagus nerve.
    1 context sentence
    Summary · context
    We showed antisecretory effects of peptides of PGP, semax and a new pancreatic hormone, amylin, on the model of continuous stomach perfusion with the registration of pH, PCO2 as well as the determination of the amount of pepsinogen in the stomach perfusate.
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In rats, intraperitoneal semax decreased hydrochloric acid production caused by irritation of the vagus nerve.

    In plain wordsIn rats, semax lowered stomach acid production triggered by nerve stimulation.

    Peptide
    Semax
    Outcome
    DecreaseHydrochloric acid production caused by vagus nerve irritation
    Study

    ratn: not reported in source

    Continuous stomach perfusion
    Outcome group
    Gastrointestinal protection · Gastrointestinal
    Studied dose
    Dose not stated · intraperitonealAs given in this study (rat).

    Source sentences

    Summary
    The intraperitoneal introduction of these peptides in the doses that proved to have an apparent anti-ulcer effect caused a decrease of both basal production of hydrochloric acid in the stomach and production caused by the irritation of the vagus nerve.
    1 context sentence
    Summary · context
    We showed antisecretory effects of peptides of PGP, semax and a new pancreatic hormone, amylin, on the model of continuous stomach perfusion with the registration of pH, PCO2 as well as the determination of the amount of pepsinogen in the stomach perfusate.
  3. 03AnimalAnimal study (in vivo)Efficacy outcome

    In rats, semax decreased basal secretion of pepsinogen in the stomach.

    In plain wordsIn rats, semax lowered the normal secretion of the stomach enzyme precursor pepsinogen.

    Peptide
    Semax
    Outcome
    DecreaseBasal pepsinogen secretion
    Study

    ratn: not reported in source

    Continuous stomach perfusion
    Outcome group
    Gastrointestinal protection · Gastrointestinal
    Studied dose
    Dose not stated · intraperitonealAs given in this study (rat).

    Source sentences

    Summary
    Semax and amylin also decreased basal and stimulated secretion of pepsinogen.
    1 context sentence
    Summary · context
    We showed antisecretory effects of peptides of PGP, semax and a new pancreatic hormone, amylin, on the model of continuous stomach perfusion with the registration of pH, PCO2 as well as the determination of the amount of pepsinogen in the stomach perfusate.
  4. 04AnimalAnimal study (in vivo)Efficacy outcome

    In rats, semax decreased stimulated secretion of pepsinogen in the stomach.

    In plain wordsIn rats, semax lowered the stimulated secretion of the stomach enzyme precursor pepsinogen.

    Peptide
    Semax
    Outcome
    DecreaseStimulated pepsinogen secretion
    Study

    ratn: not reported in source

    Continuous stomach perfusion
    Outcome group
    Gastrointestinal protection · Gastrointestinal
    Studied dose
    Dose not stated · intraperitonealAs given in this study (rat).

    Source sentences

    Summary
    Semax and amylin also decreased basal and stimulated secretion of pepsinogen.
    1 context sentence
    Summary · context
    We showed antisecretory effects of peptides of PGP, semax and a new pancreatic hormone, amylin, on the model of continuous stomach perfusion with the registration of pH, PCO2 as well as the determination of the amount of pepsinogen in the stomach perfusate.
  5. 05AnimalAnimal study (in vivo)Efficacy outcome

    In rats, semax caused a short-time increase in basal bicarbonate secretion of the stomach 35 minutes after its introduction.

    In plain wordsIn rats, semax briefly raised stomach bicarbonate secretion 35 minutes after it was given.

    Peptide
    Semax
    Outcome
    IncreaseBasal bicarbonate secretion
    Study

    ratn: not reported in source

    Continuous stomach perfusion
    Outcome group
    Gastrointestinal protection · Gastrointestinal
    Studied dose
    Dose not stated · intraperitonealAs given in this study (rat).

    Source sentences

    Summary
    Amylin and PGP did not have any effect on basal bicarbonate secretion of the stomach, and semax caused its short-time increase 35 minutes after the introduction.
    1 context sentence
    Summary · context
    We showed antisecretory effects of peptides of PGP, semax and a new pancreatic hormone, amylin, on the model of continuous stomach perfusion with the registration of pH, PCO2 as well as the determination of the amount of pepsinogen in the stomach perfusate.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 17:28 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.